Cargando…

Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer

Hereditary breast cancer is most commonly attributed to germline BRCA1 and BRCA2 gene variants. The vast majority of BRCA1 and BRCA2 mutation carriers are single heterozygotes, and double heterozygosity (DH) is a very rare finding. Here, we describe the case of a BRCA1/BRCA2 double heterozygous fema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madar, László, Majoros, Viktória, Szűcs, Zsuzsanna, Nagy, Orsolya, Babicz, Tamás, Butz, Henriett, Patócs, Attila, Balogh, István, Koczok, Katalin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607119/ https://www.ncbi.nlm.nih.gov/pubmed/37895014 http://dx.doi.org/10.3390/ijms242015334

Ejemplares similares

Application of Multilayer Evidence for Annotation of C-Terminal BRCA2 Variants
por: Butz, Henriett, et al.
Publicado: (2021)

Complex Characterization of Germline Large Genomic Rearrangements of the BRCA1 and BRCA2 Genes in High-Risk Breast Cancer Patients—Novel Variants from a Large National Center
por: Bozsik, Anikó, et al.
Publicado: (2020)

Reclassification of Five BRCA1/2 Variants with Unknown Significance Using Complex Functional Study
por: Bozsik, Anikó, et al.
Publicado: (2022)

Establishing the Mutational Spectrum of Hungarian Patients with Familial Hypercholesterolemia
por: Madar, László, et al.
Publicado: (2022)

Case Report: A Novel Pathomechanism in PEComa by the Loss of Heterozygosity of TP53
por: Butz, Henriett, et al.
Publicado: (2022)

PALB2 Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer
por: Butz, Henriett, et al.
Publicado: (2023)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Wnt-Signaling Regulated by Glucocorticoid-Induced miRNAs
por: Butz, Henriett, et al.
Publicado: (2021)

Helsmoortel–Van der Aa Syndrome—Cardiothoracic and Ectodermal Manifestations in Two Patients as Further Support of a Previous Observation on Phenotypic Overlap with RASopathies
por: Szabó, Tímea Margit, et al.
Publicado: (2022)

A Comprehensive Analysis of Hungarian MODY Patients—Part II: Glucokinase MODY Is the Most Prevalent Subtype Responsible for about 70% of Confirmed Cases
por: Gaál, Zsolt, et al.
Publicado: (2021)

Ser80Ile mutation and a concurrent Pro25Leu variant of the VHL gene in an extended Hungarian von Hippel-Lindau family
por: Patocs, Attila, et al.
Publicado: (2008)

Value of the loss of heterozygosity to BRCA1 variant classification
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2022)

A Comprehensive Analysis of Hungarian MODY Patients—Part I: Gene Panel Sequencing Reveals Pathogenic Mutations in HNF1A, HNF1B, HNF4A, ABCC8 and INS Genes
por: Gaál, Zsolt, et al.
Publicado: (2021)

An Ultra-Rare Manifestation of an X-Linked Recessive Disorder: Duchenne Muscular Dystrophy in a Female Patient
por: Szűcs, Zsuzsanna, et al.
Publicado: (2022)

Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
por: Beckmann, M. W., et al.
Publicado: (1996)

Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients
por: Bang, Yoon Ju, et al.
Publicado: (2022)

Biochemical and Clinical Effects of Vitamin E Supplementation in Hungarian Smith-Lemli-Opitz Syndrome Patients
por: Koczok, Katalin, et al.
Publicado: (2021)

MicroRNAs in endocrine tumors
por: Butz, Henriett, et al.
Publicado: (2019)

Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression
por: Butz, Henriett, et al.
Publicado: (2022)

BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts
por: Jonsdottir, Asta Björk, et al.
Publicado: (2009)

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
por: Rebbeck, Timothy R., et al.
Publicado: (2016)

Context-Dependent Role of Glucocorticoid Receptor Alpha and Beta in Breast Cancer Cell Behaviour
por: Butz, Henriett, et al.
Publicado: (2023)

Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma.
por: BiÃ¨che, I., et al.
Publicado: (1997)

Mechanisms of increased risk of tumorigenesis in Atm and Brca1 double heterozygosity
por: Wang, Jufang, et al.
Publicado: (2011)

Aspirin Mediates Its Antitumoral Effect Through Inhibiting PTTG1 in Pituitary Adenoma
por: Szabó, Borbála, et al.
Publicado: (2022)

Molecular genetic testing strategies used in diagnostic flow for hereditary endocrine tumour syndromes
por: Butz, Henriett, et al.
Publicado: (2021)

Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors
por: Krokker, Lilla, et al.
Publicado: (2021)

Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer
por: Machackova, Eva, et al.
Publicado: (2008)

Molecular genetic diagnostics of hypogonadotropic hypogonadism: from panel design towards result interpretation in clinical practice
por: Butz, Henriett, et al.
Publicado: (2020)

MicroRNAs, Long Non-Coding RNAs, and Circular RNAs: Potential Biomarkers and Therapeutic Targets in Pheochromocytoma/Paraganglioma
por: Turai, Peter Istvan, et al.
Publicado: (2021)

Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity
por: Sokol, Ethan S., et al.
Publicado: (2020)

Germline BRCA1 Mutation Detected in a Multiple Endocrine Neoplasia Type 2 Case With RET Codon 634 Mutation
por: Sarkadi, Balázs, et al.
Publicado: (2019)

Analytical parameters and validation of homopolymer detection in a pyrosequencing-based next generation sequencing system
por: Ivády, Gergely, et al.
Publicado: (2018)

Analytical Performance of NGS-Based Molecular Genetic Tests Used in the Diagnostic Workflow of Pheochromocytoma/Paraganglioma
por: Sarkadi, Balazs, et al.
Publicado: (2021)

Molecular Analysis of Cystic Fibrosis Patients in Hungary – An Update to the Mutational Spectrum
por: Ivády, Gergely, et al.
Publicado: (2015)

Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations
por: Gonzalez, R, et al.
Publicado: (1999)

Beyond BRCA1 and BRCA2: Deleterious Variants in DNA Repair Pathway Genes in Italian Families with Breast/Ovarian and Pancreatic Cancers
por: Germani, Aldo, et al.
Publicado: (2020)

Ethnic‐specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population
por: Qin, Zixin, et al.
Publicado: (2022)

In silico analysis for determining the deleterious nonsynonymous single nucleotide polymorphisms of BRCA genes
por: Yadegari, Fatemeh, et al.
Publicado: (2019)

Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach
por: Sarkadi, Balazs, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jumh18col4amdh8k51gll48dq9